Arocell
Latest round
- Series B
Last raised
- Sep 2025
Total raised
- $2.9M
Investors
- 3
About Arocell
Arocell, based in South Korea, is focused on developing premium skincare solutions that rejuvenate and enhance skin vitality, leveraging advanced ingredients for effective anti-aging benefits., Ltd, specializing in skincare products designed to target aging and environmental damage. There are no indications of structural changes or pivots in the company’s operations since its founding., Ltd, specializes in skincare products designed to rejuvenate and revitalize skin. Their core offerings include a range of products such as the Super Power Cream and Hydrogel Collagen Mask, both infused with growth factors aimed at enhancing skin elasticity and hydration. These products function by delivering essential nutrients and collagen directly to the skin, targeting aging and environmental damage. AROCELL primarily serves consumers looking for effective anti-aging solutions and is marketed in various geographical regions, including North America, Europe, and select markets in Asia.The revenue structure of Arocell is primarily generated through direct-to-consumer sales of its skincare products. Customers typically purchase items like the Super Power Cream and Hydrogel Collagen Mask directly from the company’s website or through exclusive retail partnerships. Transactions may involve one-time purchases or the establishment of subscription services for recurring deliveries of their products. Arocell's pricing strategy reflects its premium positioning in the skincare market, with specific pricing plans established for each product line, ensuring both accessibility for consumers and profitability for the company. This transactional model allows AROCELL to maintain a steady revenue stream while building brand loyalty amongst its clientele. Arocell is also focused on developing new skincare products and expanding into additional markets, though specific details about new products or targeted regions have not been disclosed.
Who invested in Arocell
3 investors across 1 round
See all investors in Arocell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 18, 2025
Amount
$2.9M
Investors
Questions about Arocell
Who invested in Arocell?
Arocell has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arocell raised?
Arocell has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Arocell last raise money?
Arocell's most recent round on record is a Series B, in Sep 2025.
What does Arocell do?
Arocell, based in South Korea, is focused on developing premium skincare solutions that rejuvenate and enhance skin vitality, leveraging advanced ingredients for effective anti-aging benefits.
Where is Arocell headquartered?
Arocell is headquartered in Seoul, South Korea.
Which VCs invest in companies like Arocell?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back consumer products companies at Arocell's stage. Their profiles are linked below.
VCs backing consumer products startups at Series B
Raising like Arocell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.